Atomoxetine as an adjunct to nonpharmacological treatments for preventing vasovagal attacks in patients with recurrent vasovagal syncope: A pilot randomized-controlled trial

BACKGROUND: Despite the reduced quality of life in patients with recurrent vasovagal syncope (VVS), pharmacologic treatment options remain limited. Studies indicate that norepinephrine reuptake inhibition reduces tilt-induced syncope/pre-syncope. This study aimed to evaluate the effects of atomoxeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajdini, Masih, Aminorroaya, Arya, Tavolinejad, Hamed, Tofighi, Saeed, Jalali, Arash, Sadeghian, Saeed, Vasheghani-Farahani, Ali, Yadangi, Somayeh, Shahmansouri, Nazila, Akhondzadeh, Shahin, Bozorgi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129927/
https://www.ncbi.nlm.nih.gov/pubmed/34027030
http://dx.doi.org/10.1016/j.ijcha.2021.100789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129927/
https://www.ncbi.nlm.nih.gov/pubmed/34027030
http://dx.doi.org/10.1016/j.ijcha.2021.100789

Ejemplares similares